Melinda Brown - May 27, 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Melinda Brown
Stock symbol
DTIL
Transactions as of
May 27, 2025
Transactions value $
$0
Form type
4
Date filed
6/4/2025, 05:00 PM
Previous filing
Mar 28, 2025
Next filing
Jun 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brown Melinda Director C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM /s/ Dario Scimeca, Attorney-in-Fact for Melinda Brown 2025-06-04 0001682988

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +9.83K +108.49% 18.9K May 27, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -9.83K -100% $0.00 0 May 27, 2025 Common Stock 9.83K Direct F2, F3
transaction DTIL Restricted Stock Units Award $0 +21K $0.00 21K Jun 3, 2025 Common Stock 21K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of Restricted Stock Units ("RSUs") on May 27, 2025.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
F4 The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.